SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Scott who wrote (774)8/17/1999 12:01:00 AM
From: DanZ   of 5582
 
Scott,

There are several posts on this thread (or other threads on SI) from Dr. Epstein, me, and others concerning the labeling of Zicam. Zicam contains 2% of its active ingredient, which is orders of magnitude greater than stereotypical homeopathic solutions. Zicam can be labeled as homeopathic because the FDA regards zinc (and other elements, minerals, and vitamins) as homeopathic. This allowed GumTech to get Zicam to market faster and without wasting shareholder money on expensive and unnecessary Phase III trials.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News